Pg.1 Market Research

Pg.2 Pre-Product Development

Pg 3. DementiaCare App Folder Structure

Pg.4 iOS CDT Apps

Pg.5 Dementia Drugs Waiting for FDA Approval

Pg.6 Vigil's phase 1 Alzheimer's trial, including the drug being tested, the trial design, the patient population, and the trial's current status.

Pg.6.1 Proposal for Vigil Neuroscience

Pg.7 Potential benefits and drawbacks of using data from patients not using Vigil Neuroscience's drug for Alzheimer's

Pg.8 Current Market for Alzheimer’s Apps

Pg.9 Financial Plan for Test App Development and Refinement for Vigil's Phase 1 Alzheimer's Trial

Pg.10 CDT Advanced App + Features

[Pg.11 SAM.gov Grants Funding Opportunity FY2024 Development Innovation Ventures_APS](https://neuralnomics.notion.site/Pg-11-SAM-gov-Grants-Funding-Opportunity-FY2024-Development-Innovation-Ventures_APS-33f8f294cdc64c88b1548066261d8bd9)